FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Connecticut Dems Facing Legal Trouble in Desperate Attempt to Ban Glocks

Sanders says Platner has the ‘guts’ to fight billionaires despite growing scandal pileup

Ohio Gov. DeWine Revokes AI Data Center Tax Break Measures

Will the Force ever awaken?

High-profile convicts lobby for rumored Trump pardons ahead of 250th anniversary

Overall success: The small-town appeal of vintage workwear

Rubio braces for Hill grilling as Republicans join bid to curb Trump’s Iran war powers

From reality TV to city hall? Trump-backed Spencer Pratt soars in LA mayor race as Californians vote

Trump makes late-night endorsements in six states ahead of Tuesday primaries, including California

Florida beach toll booth worker killed after driver rams structure before getting stuck in sand, sheriff says

Jared Kushner’s overseas luxury resort project faces anti-corruption investigation amid violent protests

Senate Democrats offer little support as Platner faces new sexting controversy: ‘Staying out of it’

Texas teens accused of using dating apps to lure young men into violent robberies that left one victim shot

Meet the Left’s Merchant of Hate

The Truth About Genocide in America: What North American Indians Were Doing to Each Other When Europeans Arrived

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”